authors García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano García-Magariño-Alonso, Mariano
selected publications academic article in scopus miRNA signature associated with R¿CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma. Non-coding RNA Research. 5:185-190. 2020 Neurotrophic Factors and Their Receptors Are Altered by the Mere Partial IGF-1 Deficiency. Neuroscience. 404:445-458. 2019 A 42-year-old woman with untreated growth hormone insensitivity, diabetic retinopathy, and gene sequencing identifies a variant of laron syndrome. American Journal of Case Reports. 20:689-696. 2019 Primary growth hormone insensitivity and psychomotor delay. Clinical Case Reports. 6:426-431. 2018 Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke. Clinical Case Reports. 5:1852-1855. 2017 Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency. Journal of Translational Medicine. 15. 2017 Fanconi Anemia and Laron Syndrome. American Journal of the Medical Sciences. 353:425-432. 2017 IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture. Journal of Physiology and Biochemistry. 73:245-258. 2017 academic article Growth hormone insensitivity: Mexican case report.
education and training Bachelor of Biology, Universidad de Sevilla Master's Degree in Molecular Medicine: Oxidative Damage and Bioprotection, Universidad San Pablo CEU PhD, Universidad San Pablo CEU
magalon@tec.mx
